Education
About Us
Working with TipRanks
Follow Us
Globus Medical (GMED)
NYSE:GMED
Earnings Data
Report Date
Nov 11, 2025After Close (Confirmed)
Period Ending
2025 (Q3)Consensus EPS Forecast
0.78Last Year’s EPS
0.83Same Quarter Last Year
Moderate Buy
Based on 13 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The earnings call depicts a strong quarter for Globus Medical, highlighted by significant revenue growth, a successful integration of Nevro, and continued innovation. Despite some challenges in international markets and lingering supply chain issues, the overall performance and future outlook appear positive.Company Guidance
Strong Financial Performance
Globus Medical delivered Q2 sales of $745 million and non-GAAP EPS of $0.86 per share, growing 18.4% and 14.1% respectively over the prior year quarter. Free cash flow was $31.3 million, growing 18% despite the impact of the Nevro acquisition and higher CapEx spending.
U.S. Spine Business Growth
The U.S. Spine business led the way commercially, growing 5.7% as reported or 7.4% on a day-adjusted basis. Growth has been consistent, driven by increasing set and inventory availability, competitive rep hiring, and increased surgeon engagement.
Enabling Technologies Bounce Back
Enabling technologies experienced a bounce back in Q2, growing 58% sequentially to finish at $35.2 million. Despite the sequential improvement, Q2 sales were lower by 4% compared to the prior year quarter.
Nevro Acquisition and Integration
The Nevro acquisition contributed $95 million in revenue during the quarter. Significant progress was made with rolling out cost controls within Nevro, and the business finished at a near breakeven adjusted EBITDA.
Innovation and Product Launches
Globus received FDA clearance for Excelsius XR, an augmented reality navigation headset. Since the beginning of 2024, Globus has launched 21 new products across spine, trauma, and joint categories.
GMED Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
GMED Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Aug 07, 2025 | $54.07 | $58.65 | +8.47% |
May 08, 2025 | $72.46 | $55.82 | -22.96% |
Feb 20, 2025 | $84.12 | $80.28 | -4.56% |
Nov 05, 2024 | $75.58 | $82.71 | +9.43% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Globus Medical (GMED) report earnings?
Globus Medical (GMED) is schdueled to report earning on Nov 11, 2025, After Close (Confirmed).
What is Globus Medical (GMED) earnings time?
Globus Medical (GMED) earnings time is at Nov 11, 2025, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is GMED EPS forecast?
GMED EPS forecast for the fiscal quarter 2025 (Q3) is 0.78.